1. Home
  2. LITB vs IMMP Comparison

LITB vs IMMP Comparison

Compare LITB & IMMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LightInTheBox Holding Co. Ltd.

LITB

LightInTheBox Holding Co. Ltd.

HOLD

Current Price

$3.01

Market Cap

60.1M

ML Signal

HOLD

Logo Immutep Limited

IMMP

Immutep Limited

HOLD

Current Price

$0.40

Market Cap

54.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LITB
IMMP
Founded
2007
1987
Country
Singapore
Australia
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
60.1M
54.4M
IPO Year
2013
2012

Fundamental Metrics

Financial Performance
Metric
LITB
IMMP
Price
$3.01
$0.40
Analyst Decision
Hold
Analyst Count
0
3
Target Price
N/A
$5.50
AVG Volume (30 Days)
10.6K
594.2K
Earning Date
05-12-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$14.50
$445.09
Revenue Next Year
$11.59
N/A
P/E Ratio
$10.96
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.11
$0.29
52 Week High
$4.17
$3.53

Technical Indicators

Market Signals
Indicator
LITB
IMMP
Relative Strength Index (RSI) 49.44 44.89
Support Level $2.41 $0.35
Resistance Level $3.89 $0.56
Average True Range (ATR) 0.17 0.02
MACD -0.08 0.01
Stochastic Oscillator 27.81 69.60

Price Performance

Historical Comparison
LITB
IMMP

About LITB LightInTheBox Holding Co. Ltd.

LightInTheBox Holding Co Ltd is a e-commerce company, providing a diverse range of affordable lifestyle products directly to consumers. Its brands include Ador, a women's fashion brand targeting women aged 35-55; the second is a golf apparel brand focusing on female golfers aged 35 and above; the third is a women's light party dress brand for the age group of 30 and above. It offers customers products through websites and mobile applications. The company operates and reviews its performance in two segments: Product sales which consisted of online retailing of consumer products and sales to third-party sellers, and Services which consisted of the provision of logistic services to companies and individual customers.

About IMMP Immutep Limited

Immutep Ltd is a Phase three clinical biotechnology company developing novel Lymphocyte Activation Gene-3 (LAG-3) related immunotherapies for cancer and autoimmune disease. It has a diversified product portfolio that harnesses LAG-3's ability to stimulate the body's immune response to fight cancer or suppress the immune system to treat autoimmune disease. The company is focused on advancing its product candidate, eftilagimod alfa (efti), through its registrational Phase three clinical trial towards marketing approval in first-line non-small cell lung cancer (1L NSCLC). The other product candidates in its portfolio include TACTI-004, TACTI-003, AIPAC-003, TACTI-002, INSIGHT-005, and others, being developed as potential therapies for various cancers and autoimmune diseases.

Share on Social Networks: